Betashares Global Shares Ex Us ETF (ASX:EXUS)
Australia · Delayed Price · Currency is AUD 35.77
-0.49 (-1.35%)
At close: May 11, 2026
1.19% (1Y)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | 17.36 |
| Dividend (ttm) | 0.04 |
| Dividend Yield | 0.10% |
| Ex-Dividend Date | Jan 2, 2026 |
| Payout Frequency | n/a |
| Payout Ratio | 1.72% |
| 1-Year Return | n/a |
| Volume | 14,985 |
| Open | 36.30 |
| Previous Close | 36.26 |
| Day's Range | 35.66 - 36.30 |
| 52-Week Low | 33.07 |
| 52-Week High | 37.50 |
| Beta | n/a |
| Holdings | 877 |
| Inception Date | Nov 6, 2025 |
About EXUS
EXUS.AX was created on 2025-11-06 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The investment objective of the Betashares Global Shares Ex US ETF is to provide an investment return that aims to track the performance of the Solactive GBS Developed Markets ex Australia and United States Large & Mid Cap AUD Index (the Index), before taking into account fees and expenses
Asset Class Equity
Category Total Market
Stock Exchange Australian Securities Exchange
Ticker Symbol EXUS
Provider BetaShares
Index Tracked Solactive GBS Developed Markets ex Australia and United States Large & Mid Cap AUD Index - AUD - Benchmark TR Net
Top 10 Holdings
12.39% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML HOLDING NV | ASML.NA | 2.48% |
| HSBC Holdings plc | HSBA | 1.31% |
| ROCHE HOLDING AG | ROP.SE | 1.21% |
| NOVARTIS AG | NOVN.SE | 1.17% |
| AstraZeneca PLC | AZN | 1.17% |
| ROYAL BANK OF CANADA | RY.CT | 1.08% |
| NESTLE SA | NESN.SE | 1.08% |
| Shell plc | SHEL | 1.03% |
| SIEMENS AG | SIE.GY | 1.00% |
| MITSUBISHI UFJ FINANCIAL GROUP | 8306.JT | 0.86% |